Ravindra Kumar is CSO & VP at ACCELERON PHARMA INC (XLRN). They have made 10 open-market trades across 1 company since 2016, most recently 2019-09-10.
CIK 0001280600
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XLRN | 86,986 | $15.5M |
Shares reported on the most recent Form 4, priced at the 2019-09-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLRN | SELL | 2019-09-10 | 2019-09-10 | $45.24 | $153K | -5.7% | -16.1% | +9.2% |
| XLRN | SELL | 2019-04-09 | 2019-04-11 | $44.62 | $154K | -7.1% | -6.9% | -5.0% |
| XLRN | SELL | 2019-01-02 | 2019-01-04 | $42.87 | $232K | +2.4% | +3.4% | +10.7% |
| XLRN | SELL | 2018-01-02 | 2018-01-04 | $42.41 | $182K | +4.6% | -9.5% | -10.8% |
| XLRN | SELL | 2017-09-12 | 2017-09-14 | $38.31 | $176K | -11.5% | -4.2% | -5.1% |
| XLRN | SELL | 2017-08-08 | 2017-08-09 | $35.41 | $463K | -7.0% | +7.8% | +0.1% |
| XLRN | SELL | 2016-10-10 | 2016-10-11 | $34.14 | $575K | -13.3% | +8.0% | -21.2% |
| XLRN | SELL | 2016-10-07 | 2016-10-11 | $33.37 | $655K | -13.3% | +8.0% | -21.2% |
| XLRN | SELL | 2016-10-06 | 2016-10-11 | $34.38 | $550K | -13.3% | +8.0% | -21.2% |
| XLRN | SELL | 2016-10-06 | 2016-10-11 | $33.92 | $1.8M | -13.3% | +8.0% | -21.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.